from sdb ssr.com scott ballantyn subject re burzynski' antineoplaston articl jschwimmer wccnet.wcc.wesleyan.edu jschwimmer wccnet.wcc.wesleyan.edu josh schwimmer write ani opinion burzynski' antineoplaston inform about current statu hi research would appreci burzynski' work too promis none hi through antineoplaston have been shown have antineoplast effect against experiment cancer nci conduct test against leukemia mice result dose high enough produc toxic effect mice were effect inhibit growth tumor kill were burzynski claim activ factor common all someth which he ha shown ha onli been extract from he also hasn't shown through actual distinct substanc nci conduct seri test us against standard panel tumor includ differ cell line from tumor follow class leukemia non small cell small cell lung cancer colon cancer cancer central nervou system melanoma ovarian cancer renal cancer exhibit neither growth inhibit nor cytotox dose level test necessari process sinc solubl burzynski' theori requir solubl agent basic hydrol pag which he call pag inform carri peptid someth which byrzynski claim necessari antineoplast activ also deriv from mixtur pa pag pa also peptid can purchas chemic suppli hous about gram chemic extrem similar glutithamid thalidomid both which habit form can caus peripher neuropathi nasti effect thalidomid wide known spite similar doe appear have been test it' potenti induc teratogen peripher neuropathi mani burzynski' statement about origin hi theori earli research past present support other hi work have been shown untru sdb sdb ssr.com 